Suppr超能文献

凝血酶及凝血酶/血栓调节蛋白复合物对受体结合型尿激酶型纤溶酶原激活剂(pro-uPA)的灭活作用

Inactivation of receptor-bound pro-urokinase-type plasminogen activator (pro-uPA) by thrombin and thrombin/thrombomodulin complex.

作者信息

Wilhelm S, Wilhelm O, Schmitt M, Graeff H

机构信息

Frauenklinik Technischen Universität München, Germany.

出版信息

Biol Chem Hoppe Seyler. 1994 Sep;375(9):603-8. doi: 10.1515/bchm3.1994.375.9.603.

Abstract

Urokinase-type plasminogen activator (uPA) binds with high affinity to a specific cell surface glycosyl phosphatidyl-inositol (GPI)-anchored receptor, the urokinase receptor (uPAR). Pro-uPA, the enzymatically inactive single-chain form of uPA after having been activated by certain proteases, converts plasminogen into plasmin. This activation of pro-uPA to enzymatically active uPA can be prevented by the action of thrombin on pro-uPA. This inactivation process is accelerated in the presence of thrombomodulin (TM). The present study investigated whether pro-uPA bound to uPAR is still susceptible to inactivation by thrombin in the presence or absence of TM. A truncated soluble form of the uPAR lacking the GPI-anchor was cloned and expressed in CHO-cells (rec-uPAR277). Rec-uPAR277 efficiently inhibited the thrombin-mediated inactivation of pro-uPA up to 90% in a concentration dependent manner. The protective effect of rec-uPAR277 was far less pronounced when thrombin was complexed with TM. Enzyme kinetic experiments with varying concentrations of pro-uPA showed that in the presence of TM the catalytic efficiency (kcat/Km) of thrombin-mediated inactivation raised from 0.010 microM-1 s-1 to 0.50 microM-1 s-1 corresponding to a fifty-fold increase. In the presence of rec-uPAR277, however, the catalytic efficiency dropped by 4.1-fold (0.5 microM-1 s-1 to 0.122 microM-1 s-1). The inactivation kinetics of pro-uPA by thrombin (no TM added) in the presence of an excess of rec-uPAR277 could not be determined since virtually no inactivation occurred. Our data suggest that pro-uPA once bound to uPAR, is significantly protected from inactivation by thrombin.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

尿激酶型纤溶酶原激活剂(uPA)与一种特定的细胞表面糖基磷脂酰肌醇(GPI)锚定受体——尿激酶受体(uPAR)以高亲和力结合。前尿激酶原是uPA的无酶活性单链形式,在被某些蛋白酶激活后可将纤溶酶原转化为纤溶酶。凝血酶作用于前尿激酶原可阻止其激活为有酶活性的uPA。在血栓调节蛋白(TM)存在时,这种失活过程会加速。本研究调查了结合到uPAR上的前尿激酶原在有无TM存在的情况下是否仍易受凝血酶失活作用的影响。一种缺失GPI锚的截短可溶性uPAR形式被克隆并在CHO细胞中表达(重组uPAR277)。重组uPAR277以浓度依赖方式有效抑制凝血酶介导的前尿激酶原失活达90%。当凝血酶与TM结合时,重组uPAR277的保护作用明显减弱。用不同浓度前尿激酶原进行的酶动力学实验表明,在TM存在时,凝血酶介导失活的催化效率(kcat/Km)从0.010微摩尔-1秒-1提高到0.50微摩尔-1秒-1,相当于增加了50倍。然而,在重组uPAR277存在时,催化效率下降了4.1倍(从0.5微摩尔-1秒-1降至0.122微摩尔-1秒-1)。在过量重组uPAR277存在的情况下,由于几乎没有失活发生,所以无法确定凝血酶(未添加TM)对前尿激酶原的失活动力学。我们的数据表明,一旦结合到uPAR上,前尿激酶原就受到显著保护而免受凝血酶失活作用。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验